Tuberculosis and Respiratory Diseases

Original Article

COPD

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients

Eun-Yeong Cho, Jung-Eun Cho, Eun-Bin Lee, et al.

Tuberc Respir Dis. 2023;86(1):33-46. Published online November 28, 2022

Background: Umeclidinium/vilanterol (UMEC/VI; ANORO ELLIPTA, GSK) is a commonly used dual bronchodilator. This study evaluated the safety and effectiveness of UMEC/VI in Korean patients with chronic obstructive pulmonary disease (COPD) over a 6-year period. Methods: This was an open-label, multicentre, observational, post-marketing surveillance study. A total of 3,375 patients were enrolled consecutively in 52 hospitals, by 53 physicians, between July 2014...

DOI: https://doi.org/10.4046/trd.2022.0055

Original Article

Tuberculosis

Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020

Keun Ju Kim, Seung-Hwan Oh, Doosoo Jeon, et al.

Tuberc Respir Dis. 2023;86(1):47-56. Published online December 8, 2022

Background: There is a global increase in isolation of nontuberculous mycobacteria (NTM). The aim of the study was to analyze longitudinal trends of NTM identification and pattern of antimicrobial susceptibility testing. Methods: NTM recovery rates, distribution of NTM species identification, and antimicrobial susceptibility pattern of NTM at Pusan National University Yangsan Hospital between January 2016 and December 2020 were retrospectively analyzed. Results:...

DOI: https://doi.org/10.4046/trd.2022.0115

Current Issue: Volume 86(1); Jan 2023

Reviews

Lung Cancer

New Targeted Therapy for Non-Small Cell Lung Cancer: Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee; Tuberc Respir Dis. 2023;86(1):1-13. Published online October 5, 2022; DOI: https://doi.org/10.4046/trd.2022.0066; Full text PubReader ePub Crossref - TDM PDF

Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse: Jeong Uk Lim; Tuberc Respir Dis. 2023;86(1):14-22. Published online October 26, 2022; DOI: https://doi.org/10.4046/trd.2022.0081; Full text PubReader ePub Crossref - TDM PDF

Environmental and Occupational Lung Disease

Review of Internet of Things-Based Artificial Intelligence Analysis Method through Real-Time Indoor Air Quality and Health Effect Monitoring: Focusing on Indoor Air Pollution That Are Harmful to the Respiratory Organ: EunMi Mun, Jaehyuk Cho; Tuberc Respir Dis. 2023;86(1):23-32. Published online October 26, 2022; DOI: https://doi.org/10.4046/trd.2022.0087; Full text PubReader ePub Crossref - TDM PDF

Original Articles

COPD

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients: Eun-Yeong Cho, Jung-Eun Cho, Eun-Bin Lee, Seung Soo Yoo, Jung Hyun Chang; Tuberc Respir Dis. 2023;86(1):33-46. Published online November 28, 2022; DOI: https://doi.org/10.4046/trd.2022.0055; Full text PubReader ePub Crossref - TDM PDF

Tuberculosis

Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020: Keun Ju Kim, Seung-Hwan Oh, Doosoo Jeon, Chulhun L. Chang; Tuberc Respir Dis. 2023;86(1):47-56. Published online December 8, 2022; DOI: https://doi.org/10.4046/trd.2022.0115; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Images of Interest

COPD

Captive: Brian Robert Smith; Tuberc Respir Dis. 2023;86(1):57-58. Published online October 25, 2022; DOI: https://doi.org/10.4046/trd.2022.0130; Full text PubReader ePub Crossref - TDM PDF

Miscellaneous

Mounier-Kuhn Syndrome: Irfan Ismail Ayub, Krishnamoorthy Vengadakrishnan; Tuberc Respir Dis. 2023;86(1):59-60. Published online December 7, 2022; DOI: https://doi.org/10.4046/trd.2022.0123; Full text PubReader ePub Crossref - TDM PDF

Letters to the Editor

COPD

Definition of Chronic Obstructive Pulmonary Disease Exacerbation: The Essentials of the Rome Proposal: Yeon-Mok Oh; Tuberc Respir Dis. 2023;86(1):61-62. Published online December 5, 2022; DOI: https://doi.org/10.4046/trd.2022.0119; Full text PubReader ePub Crossref - TDM PDF

Critical Care Medicine

Early Use of High Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate?: Prosenjit Mukherjee, Mohanchandra Mandal, Antonio M. Esquinas; Tuberc Respir Dis. 2023;86(1):63-64. Published online December 7, 2022; DOI: https://doi.org/10.4046/trd.2022.0113; Full text PubReader ePub Crossref - TDM PDF

Early Use of High-Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate? Authors’ Reply: Jae Kyeom Sim, Young Seok Lee; Tuberc Respir Dis. 2023;86(1):65-66. Published online December 12, 2022; DOI: https://doi.org/10.4046/trd.2022.0161; Full text PubReader ePub Crossref - TDM PDF

Tuberculosis

Tuberculosis: Republic of Korea, 2021: Jinsoo Min, Hyung Woo Kim, Ju Sang Kim; Tuberc Respir Dis. 2023;86(1):67-69. Published online October 25, 2022; DOI: https://doi.org/10.4046/trd.2022.0111; Full text PubReader ePub Crossref - TDM PDF

Volume 86, No. 1

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

10,028	The Long-term Efficacy of Domiciliary Noninvasive Positive-Pressure Ventilation in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials
6,727	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
12,393	Revised Korean Cough Guidelines, 2020: Recommendations and Summary Statements
6,207	Role of Nuclear Factor Erythroid 2-Related Factor 2 in Chronic Obstructive Pulmonary Disease
4,271	Respiratory Reviews in Asthma 2022

Cited By 15	COVID-19 Death and BCG Vaccination Programs Worldwide
Cited By 12	Recent Trends of Lung Cancer in Korea
Cited By 9	Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
Cited By 9	The Association between Mortality and the Oxygen Saturation and Fraction of Inhaled Oxygen in Patients Requiring Oxygen Therapy due to COVID-19–Associated Pneumonia
Cited By 7	Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public–Private Mix Periods

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org

Copyright © 2023 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

prev

next

prev

next